Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Medicine|June 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trialAditi R Saxena, Donal N Gorman, Ryan M Esquejo, et al.
Cell Metabolism|August 30, 2016
SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a RegulationManuel Roqueta-Rivera, Ryan M Esquejo, Peter E Phelan, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 14, 2020
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour modelBarbara Bernardo, Stephanie Joaquim, Jeonifer Garren, et al.
Cell Chemical Biology|October 23, 2020
Dipyridamole Inhibits Lipogenic Gene Expression by Retaining SCAP-SREBP in the Endoplasmic ReticulumRyan M Esquejo, Manuel Roqueta-Rivera, Wei Shao, et al.
Nature Communications|April 8, 2015
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosisJi Miao, Alisha V Ling, Praveen V Manthena, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 13, 2026
Targeting Cancer Cachexia: A Mechanistic Evaluation of Anti-GDF-15 Antibody-Based Combination TherapiesDanna M Breen, Stephanie Joaquim, Brianna LaCarubba Paulhus, et al.
Molecular Metabolism|May 31, 2025
Uncovering the role of Gpr45 in obesity regulationEva O Karolczak, Chia Li, Ivan C Alcantara, et al.
Molecular Metabolism|February 12, 2026
GIPR signaling modulates PYY-induced hypophagia and malaise in rodentsTito Borner, Allison M Pataro, Genevieve R Curtis, et al.
Pageof 2